MicroRNA-Governed Autocatalytic Fenton Nanoplatform for Cancer-Selective Theranostics
evaluations demonstrate high-contrast tumor imaging and effective suppression of tumor growth. This research introduces a class of tumor-specific CDT that transcends conventional material design by leveraging intrinsic biological intelligence for precise and personalized anticancer therapy.
Authors
- Fei Ma (ORCID: https://orcid.org/0000-0002-2967-8013)
- Chun‐yang Zhang (ORCID: https://orcid.org/0000-0002-8010-1981)
- Lu-yao Wang
- Wen-jing Liu
Publication Details
- Journal
- ACS Nano
- Published
- 2026-04-22
- DOI
- https://doi.org/10.1021/acsnano.6c01960
- Primary Topic
- Advanced biosensing and bioanalysis techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Jiangsu Provincial Key Research and Development Program
- National Key Research and Development Program of China